Buy Adamas Pharmaceuticals Stock | ADMS Stock Price & Latest News | Public
ADMS

Adamas Pharmaceuticals

$0.00 (0.00%)Today
    Small Market Cap

    About ADMS

    Adamas Pharmaceuticals, Inc. engages in discovery and development of chrono-synchronous therapies for chronic neurologic disorders. Its products include GOCOVRI, ADS-5012, ADS-4101, and Namzaric. GOCOVRI is indicated for the treatment of dyskinesia in patients with Park...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.2
    -0.4
    -0.59
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.53

    Actual EPS
    Q4 2020

    Stats

    Market Cap$126,91M
    Volume6,26k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$7.45
    1 Year Low$1.90
    Open$4.47
    High$4.55
    Low$4.46

    Buy any stock with any amount of money.

    Download the App
    Download the app